Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02215395Phase 1Completed
Phase 1, randomised, open-label trial of segesterone and ethinyl estradiol, sponsored by Population Council. Primary endpoint: Drug Drug Interaction of NES/EE CVR and topical anti-fungal medication at Week 12. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02215395.